Vimarsana
Biggest News Aggregation in the World

Page 3 - Term Assets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Term Assets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Term Assets Today - Breaking & Trending Today

Rice Acquisition II : Consolidated Financial Statements - Form 8-K - Vimarsana News

Rice Acquisition II : Consolidated Financial Statements - Form 8-K

Consolidated Financial Statements As of and for the Three Months Ended March 31, 2023 and 2022 and as of the Year Ended December 31, 2022 NET Power, LLC ... | June 14, 2023

QualTek Services : DISCLOSURE STATEMENT RELATING TO THE DEBTORS' JOINT PLAN OF REORGANIZATION PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE - Form 8-K - Vimarsana News

QualTek Services : DISCLOSURE STATEMENT RELATING TO THE DEBTORS' JOINT PLAN OF REORGANIZATION PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE - Form 8-K

DISCLOSURE STATEMENT RELATING TO THE DEBTORS' JOINT PLAN OF REORGANIZATION PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE ... | May 31, 2023

Wix Reports First Quarter 2023 Results - Vimarsana News

Wix Reports First Quarter 2023 Results

Strong profitable start to the year with total revenue of $374.1 million in the first quarter exceeding expectations, up 10% y/y, marked by acceleration in...

Moving iMage Technologies Announces Third Quarter Fiscal 2023 Results - Vimarsana News

Moving iMage Technologies Announces Third Quarter Fiscal 2023 Results

$0.06 - $0.07 Diluted Shares Outstanding 10.9 million 10.6 million 0.3 million “Our updated guidance reflects the impact of the project pushes... | May 15, 2023

BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...